ArticleNPJ digital medicine2026
Fourier Kolmogorov-Arnold Network integrated into BioBERT-based model for Biomedical Named Entity Recognition.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Biomedical Named Entity Recognition (BioNER) extracts entities such as diseases, drugs, and genes from biomedical texts, which are often dense in domain-specific terms and complex semantics. Here, we present FRKAN-BioNER, a model designed to improve the efficiency of data mining in the biomedical field and support the development of precision medicine knowledge graphs. FRKAN-BioNER integrates BioBERT (Bidirectional Encoder Representations from Transformers for Biomedical Text Mining) with the Fourier Kolmogorov-Arnold Network (FourierKAN). The KAN architecture addresses limitations in traditional neural networks, improving model expressiveness and trainability. The model achieved F1-score of 84.80%, 93.12%, 90.02%, 82.10%, 87.90%, 83.14%, 78.58%, 89.93%, and 90.87% across nine public datasets. These results demonstrate that FRKAN-BioNER outperforms several prior state-of-the-art methods. Furthermore, its innovative architecture may hold potential for improving the efficiency of BioNER-relevant clinical text processing and could help accelerate knowledge mining from large-scale biomedical literature.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.